Uncovering the detailed mode of cleavage of heparinase I toward structurally defined heparin oligosaccharides.

Int J Biol Macromol

Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, PR China; National Glycoengineering Research Center, Shandong University, Jinan 250012, Shandong, PR China. Electronic address:

Published: December 2019

For a more insightful investigation into the specificity of bacterial heparinase I, a series of structurally well-defined heparin oligosaccharides was synthesized using a highly efficient chemoenzymatic strategy. Apart from the primary cleavage site, five glycosidic linkages of oligosaccharides with varying modifications to obtain secondary cleavage sites were degraded by a high concentration of heparinase I. The reactivity of linkages toward heparinase I was not entirely dependent on the 2-O-sulfated iduronic acid being cleaved or the neighboring 6-O-sulfated glucosamine residues, but it was dependent on higher degrees of sulfation of oligosaccharides and indispensable N-substituted glucosamine adjacent to the cleavable linkage. Moreover, the enzyme demonstrated less preferential cleavage toward glycosidic linkages containing glucuronic acid than those containing iduronic acid of the counterpart oligosaccharides. Biolayer interferometry revealed differences in reactivity that are not completely consistent with different affinities of substrates to enzyme. Our study presented accurate information on the cleavage promiscuity of heparinase I that is crucial for heparin depolymerization.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2019.08.260DOI Listing

Publication Analysis

Top Keywords

heparin oligosaccharides
8
glycosidic linkages
8
iduronic acid
8
cleavage
5
heparinase
5
oligosaccharides
5
uncovering detailed
4
detailed mode
4
mode cleavage
4
cleavage heparinase
4

Similar Publications

The chitinase-like protein YKL-40 (CHI3L1) has been implicated in the pathophysiology of inflammation and cancer. Recent studies highlight the growing interest in targeting and blocking the activity of YKL-40 to treat cancer. Some of those targeting-strategies have been developed to directly block the heparin-affinity of YKL-40 with promising results.

View Article and Find Full Text PDF
Article Synopsis
  • Heparanase is a key enzyme in the breakdown of heparan sulfate, contributing to tumor growth and metastasis, making it a target for cancer treatments.
  • Researchers synthesized specific trisaccharides and a tetrasaccharide that inhibit heparanase activity, focusing on glycol-split versions as potential inhibitors.
  • Studies using STD NMR and molecular docking revealed that these glycol-split trisaccharides had stronger binding and inhibitory effects against heparanase compared to their intact forms, providing insight into their mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • Alpha-gal syndrome is triggered by tick bites, leading to IgE responses against alpha-gal, a carbohydrate present in mammalian meat, causing delayed allergic reactions 2 to 6 hours after eating.
  • Symptoms can include skin rashes, gastrointestinal issues, and occasionally severe anaphylaxis, often starting near the previous tick bite site.
  • Diagnosis involves monitoring symptom timing and prior tick bite history, with treatment focusing on immediate care during allergic reactions and long-term management requiring a strict meat-free diet.
View Article and Find Full Text PDF

Preparation and structural characterization of a sulfated octasaccharide with heparin-like anticoagulant activity.

Carbohydr Polym

January 2025

Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, 210094, China. Electronic address:

Article Synopsis
  • Heparins, derived from animal tissues, have supply limitations and risks like bleeding and thrombocytopenia, prompting research into synthetic alternatives.
  • A new approach synthesized a heparin-like anticoagulant, sulfated octasaccharide (SRO), demonstrating effective anticoagulant activity in mice and humans with less bleeding risk.
  • This synthetic product, named octaparin, offers a promising replacement for traditional animal-sourced heparin.
View Article and Find Full Text PDF

Comprehensive chromatographic profiling and structural analysis of key anticoagulant components in enoxaparin.

J Chromatogr A

November 2024

College of Pharmaceutical Sciences and Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases, Soochow University, Suzhou, Jiangsu 215021, China. Electronic address:

Heparin is the most widely used anticoagulant in clinical practice, with enoxaparin being one of the most important low molecular weight heparins (LMWHs). In this study, an antithrombin III (ATIII) affinity column was used. Enoxaparin and its oligosaccharides of varying sizes, prepared using preparative size exclusion chromatography (SEC), were fractionated through the ATIII affinity column.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!